Bicalutamide
بیکالوتامید
🎗️ Antineoplastic And Immunomodulating AgentsAntiandrogen
Market / country: 🇺🇸 USA
Casodex (US)
🧮 Dose calculator
Prostate cancer · Regimen source: FDA Bicalutamide · Dosage and Administration
- • Start at the same time as the LHRH analogue; take at the same time each day. FDA Bicalutamide · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to bicalutamide (angioedema, urticaria); women (no indication); pregnancy (fetal harm). FDA Bicalutamide · Contraindications
Warnings
- • Hepatitis (periodic liver tests); gynaecomastia; increased warfarin effect. FDA Bicalutamide · Warnings
Formulations
- 50 mg tablet — tablet 🇺🇸 USA FDA Bicalutamide · How Supplied
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Bicalutamide · Precautions/Warnings – Pregnancy
“Risk Summary Bicalutamide tablets are contraindicated for use in pregnant women because it can cause fetal harm.”
- 🤱 BreastfeedingNo data
The source for this drug has no section for this group.
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Bicalutamide · Precautions/Warnings – Pediatric Use
“The safety and effectiveness of bicalutamide tablets in pediatric patients have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Bicalutamide · Precautions/Warnings – Geriatric Use
“Hepatic Impairment Bicalutamide tablets should be used with caution in patients with moderate-to-severe hepatic impairment.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA020498
- DailyMed (FDA label)FDA Bicalutamide
- MedlinePlus (NIH)Bicalutamide
- WHO ATC/DDDL02BB03
- Darooyab (Iran)Bicalutamide
🇮🇷 Registered in Iran Darooyab · G-954/Bicalutamide
Dosage forms with Iranian generic codes, per Darooyab.
- 07582 · BICALUTAMIDE 150MG TAB · قرص بیکالوتامید ۱۵۰ میلیگرم
- 06765 · BICALUTAMIDE 50MG TAB · قرص بیکالوتامید ۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Bicalutamide · How SuppliedFDA Bicalutamide · Dosage and AdministrationFDA Bicalutamide · ContraindicationsFDA Bicalutamide · WarningsFDA Bicalutamide · SPL approval / marketing categoryFDA Bicalutamide · Precautions/Warnings – PregnancyFDA Bicalutamide · Precautions/Warnings – Pediatric UseFDA Bicalutamide · Precautions/Warnings – Geriatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-954/Bicalutamide
- Clinical review⚠ Unverified